1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with pituitrin in 18 studies
Studies (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Trials (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Recent Studies (post-2010) (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Studies (pituitrin) | Trials (pituitrin) | Recent Studies (post-2010) (pituitrin) |
---|---|---|---|---|---|
35 | 0 | 0 | 22,137 | 594 | 2,101 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (55.56) | 18.7374 |
1990's | 8 (44.44) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mol, JA; Rijnberk, A; van Oosterhout, IC | 1 |
He, XR; Shi, L; Wang, WH; Yao, T | 1 |
Baláspiri, L; Janáky, T; Laczi, F; László, FA | 1 |
Bennett, T; Gardiner, SM; Tomlinson, KC | 1 |
Franco, R; Gavras, H; Gavras, I; Mulinari, RA; Wang, YX | 1 |
Arroyo, V; Asbert, M; Claria, J; Guarner, F; Jiménez, W; La Villa, G; López, C; Rivera, F; Rodés, J | 1 |
Brand, PH; Britton, SL; Metting, PJ | 1 |
Ho, PM; Tang, AH | 1 |
Baláspiri, L; László, FA | 1 |
Churchill, S; Huffman, W; Kinter, LB; Moore, M; Stassen, FL | 1 |
Heckman, GD; Huffman, WF; Kinter, LB; Stassen, FL | 1 |
Manning, M; Sawyer, WH | 1 |
Berkowitz, BA; Sherman, S | 1 |
Ishikawa, S; Schrier, RW | 1 |
Lammek, B; Manning, M; McEnroe, M; Pang, PK; Sawyer, WH; Seto, J | 1 |
Angeli, P; Arroyo, V; Bosch-Marcé, M; Clària, J; Graziotto, A; Jiménez, W; Leivas, A; Rivera, F; Rodés, J | 1 |
Matsuda, T; Mori, M; Tsushima, H | 1 |
Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y | 1 |
18 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and pituitrin
Article | Year |
---|---|
Effect of the aquaretic vasopressin antagonists d(CH2)5[D-Tyr(Et)2-Val4]AVP and d(CH2)5[D-Phe2-Phe4]AVP on urine production in healthy dogs.
Topics: Animals; Arginine Vasopressin; Dogs; Female; Osmolar Concentration; Sodium; Urodynamics; Vasopressins | 1992 |
[Role of the hypophysis in the renal responses upon stimulation of the brain osmoreceptor].
Topics: Animals; Arginine Vasopressin; Benserazide; Diuresis; Hypophysectomy; Injections, Intraventricular; Male; Natriuresis; Osmolar Concentration; Pituitary Gland; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Vasopressins; Water-Electrolyte Balance | 1992 |
Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
Topics: Animals; Arginine Vasopressin; Eye; Rats; Rats, Brattleboro; Rats, Inbred Strains; Saline Solution, Hypertonic; Vasopressins | 1991 |
Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiovascular System; Heart Rate; Male; Pentolinium Tartrate; Rats; Rats, Brattleboro; Rats, Inbred Strains; Rats, Mutant Strains; Streptozocin; Vasopressins | 1990 |
Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Diuresis; Heart Failure; Male; Rats; Rats, Inbred Strains; Ultrasonography; Vascular Resistance; Vasopressins | 1990 |
Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Diuresis; Kidney; Liver Cirrhosis, Experimental; Male; Rats; Rats, Inbred Strains; Vasopressins; Water-Electrolyte Imbalance | 1989 |
Support of arterial blood pressure by major pressor systems in conscious dogs.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Dehydration; Dogs; Female; Ganglia, Autonomic; Heart Rate; Hexamethonium; Hexamethonium Compounds; Male; Reference Values; Renin; Vasopressins | 1988 |
A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats.
Topics: Animals; Arginine Vasopressin; Blood; Brain Edema; Brain Ischemia; Diuresis; Male; Rats; Rats, Inbred F344; Vasopressins; Water-Electrolyte Balance | 1988 |
Experimental water intoxication induced by dDAVP in rat, and its prevention with the vasopressin antagonist d(CH2)5Tyr(Et)VAVP.
Topics: Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Disease Models, Animal; Inappropriate ADH Syndrome; Male; Rats; Vasopressins; Water Intoxication | 1986 |
Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Diuresis; Kidney Medulla; Male; Osmolar Concentration; Saimiri; Tyrosine; Urine; Vasopressins | 1987 |
Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.
Topics: Adenylyl Cyclases; Animals; Arginine Vasopressin; Body Water; Dogs; Dose-Response Relationship, Drug; Enzyme Activation; Guanosine Triphosphate; Kidney Cortex; Kidney Medulla; Vasopressins | 1985 |
Effective antagonists of the antidiuretic action of vasopressin in rats.
Topics: Adenylyl Cyclase Inhibitors; Animals; Arginine Vasopressin; Chemical Phenomena; Chemistry; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Dose-Response Relationship, Drug; Oxytocin; Rats; Structure-Activity Relationship; Vasopressins | 1982 |
Characterization of vasopressin analgesia.
Topics: Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Injections, Intraventricular; Male; Mice; Motor Activity; Naltrexone; Rats; Rats, Inbred Strains; Vasopressins | 1982 |
Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats.
Topics: Adrenal Glands; Adrenalectomy; Animals; Arginine Vasopressin; Desoxycorticosterone; Diuresis; Glomerular Filtration Rate; Glucocorticoids; Kidney; Male; Mineralocorticoids; Osmolar Concentration; Prednisolone; Rats; Rats, Inbred Strains; Vasopressins | 1982 |
Vasopressin analogs that antagonize antidiuretic responses by rats to the antidiuretic hormone.
Topics: Animals; Arginine Vasopressin; Diuresis; Female; Osmolar Concentration; Rats; Structure-Activity Relationship; Vasopressins | 1981 |
Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Ascites; Benzeneacetamides; Blood Pressure; Body Water; Diuresis; Heart Rate; Kidney; Liver Cirrhosis, Experimental; Male; Natriuresis; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Vasopressins | 1995 |
Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Injections, Intra-Arterial; Injections, Intraventricular; Male; Microinjections; Paraventricular Hypothalamic Nucleus; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Angiotensin; Supraoptic Nucleus; Timolol; Vasoconstriction; Vasopressins | 1994 |
Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Liver Cirrhosis, Experimental; Male; Osmolar Concentration; Rats; Rats, Wistar; Vasopressins; Water-Electrolyte Balance | 1994 |